Araldite 2014-2 Epoxy SDS

SAFETY DATA SHEET According to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 ARALDITE® 2014-2 RESIN

Version 2 . 0

Revision Date: 21.08.2025

SDS Number: 400001015910

Date of last issue: 21.06.2024 Date of first issue: 03.06.2016

Print Date 22.08.2025

Test Type: Micronucleus test Species: Rat (male and female) Application Route: Intraperitoneal injection Dose: 2500 mg/kg Method: OECD Test Guideline 474 Result: negative Test Type: Micronucleus test Species: Rat (male and female) Application Route: Intraperitoneal injection Dose: 1500 mg/kg Method: OECD Test Guideline 474 Result: negative

barium sulfate: Genotoxicity in vitro

: Metabolic activation: with and without metabolic activation Method: OECD Test Guideline 476 Result: negative Metabolic activation: with and without metabolic activation Method: OECD Test Guideline 471 Result: negative Metabolic activation: with and without metabolic activation Method: OECD Test Guideline 473 Result: negative

Carcinogenicity Not classified due to lack of data.

Components:

bis-[4-(2,3-epoxipropoxi)phenyl]propane: Species : Rat, male Application Route : Oral Exposure time : 24 month(s) Dose

: 0, 2, 15, or 100 mg/kg bw/day

Frequency of Treatment

: 7 days/week

NOAEL Method Result

: 15 mg/kg bw/day

: OECD Test Guideline 453

: negative

Target Organs

: Digestive organs

Species

: Mouse, male

Application Route

: Dermal

Exposure time

: 24 month(s)

Dose

: 0, 0.1, 10, 100 mg/kg bw/day

Frequency of Treatment

: 3 days/week

NOEL

: 0.1 mg/kg body weight : OECD Test Guideline 453

Method Result

: negative

Target Organs

: Digestive organs

Species

: Rat, female

SDS_GB-AM – 6N – 400001015910

19 / 36